Tocqueville Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,375
| Closed | -$210K | – | 834 |
|
|
2017
Q2 | $210K | Buy |
3,375
+250
| +8% | +$15.6K | ﹤0.01% | 742 |
|
|
2017
Q1 | $212K | Sell |
3,125
-300
| -9% | -$20.4K | ﹤0.01% | 748 |
|
|
2016
Q4 | $241K | Sell |
3,425
-9,775
| -74% | -$688K | ﹤0.01% | 722 |
|
|
2016
Q3 | $936K | Sell |
13,200
-3,500
| -21% | -$248K | 0.01% | 515 |
|
|
2016
Q2 | $817K | Buy |
16,700
+500
| +3% | +$24.5K | 0.01% | 533 |
|
|
2016
Q1 | $1.03M | Sell |
16,200
-150
| -0.9% | -$9.5K | 0.01% | 499 |
|
|
2015
Q4 | $1.83M | Buy |
16,350
+5,350
| +49% | +$600K | 0.02% | 438 |
|
|
2015
Q3 | $1.06M | Buy |
+11,000
| New | +$1.06M | 0.01% | 554 |
|